Business
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc..

About this update from Resonate Blends Inc.
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc. Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc. Newsfile Corp. Newsfile Corp North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in conjunction with the final due diligence being reviewed by MedwellAI, Inc. (OTCQB: MWAI) to acquire Apollo and its subsidiaries including Evolutionary Biologics, Inc. ("Evo Bio"), (the "Transaction"), MWAI has reserved a Preferred Series B class of stock for the share exchanged and assumption of certain liabilities of Apollo. Negotiations are ongoing with certain secured creditors and debtholders of the Company that need to be resolved prior to closing the transaction. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10533/291521_5f097a2a947429ff_001full.jpg In further conjunction with the efforts to close the Transaction between the companies, and simultaneously rebuild and expand the Evo Bio brand with multiple new products that are to be launched in 2026, it has been agreed that Jim Morrison, one of the founders of Apollo and Evo Bio, has agreed to re-assume his position as CEO/President and Chairman of the Board of Directors of the Company, in conjunction with the Transaction and massive expansion plans that have been put in place for EVO. Jim Morrison, as CEO/President and Chairman of the Board while simultaneously working with the current CEO, James W. Zimbler, to facilitate all that is required to close the Transaction with MWAI. Upon the take-over of the Company by MWAI, it is anticipated that Apollo will become the Evo Bio subsidiary of MWAI, and in addition to the current portfolio of Evo Bio, management plans to roll out five new products over the next two quarters and expand the offerings of Evo Bio. James W. Zimbler, President and CEO, stated, "I am honored and thrilled that Jim Morrison has agreed to resume his roll with the Company and with his expert tutelage and significant management, marketing and distribution capabilities being brought to MWAI, this is an amazing opportunity for all shareholders, debtholders and stakeholders of KOAN." Jim Morrison, incoming CEO/President and Chairman of the Board, stated, "For the last three years I have been working closely with Jim Zimbler to ensure that when the time...
View stock analysis, news, and events for Resonate Blends Inc.